Strategic partnerships SCbio is a leading unifier in South Carolina’s life sciences sector with a broad representation of academia, startups, government, and established enterprises. This presents a strong opportunity to cross-sell services or collaborate on funded research initiatives, accelerator programs, and region-wide life sciences clusters.

Global expansion Recent facility expansion to Shanghai and integration with CordenPharma’s network signals an openness to international collaboration and manufacturing partnerships, creating sales potential for peptide manufacturing, contract research, or translational services across Asia and beyond.

Strategic Advisory New members on the Strategic Advisory Board from Labcorp and consulting leadership indicate a focus on governance, strategic guidance, and industry credibility, suggesting opportunities to offer advanced analytics, digital health solutions, or regulatory/compliance consulting to elevated members.

Industry visibility Active participation in BIO events and Global Health initiatives with UN Foundation enhances SCbio’s network reach and access to potential sponsors, funders, and partner institutions, creating avenues for sponsored research programs, grant-ready collaborations, and joint ventures.

Financial potential With reported revenue in the mid-range for a mid-sized industry group and a member base representing thousands of professionals, there is room to offer enterprise-grade technology stacks, data analytics platforms, and efficiency solutions to scale member organizations and monetize regional life sciences ecosystems.